articles
- Toward directing opioid receptor signaling to refine opioid therapeutics. 87:15-21. 2020
- Animal models of addiction and neuropsychiatric disorders and their role in drug discovery: honoring the legacy of Athina Markou. 83:940-946. 2018
- Contribution to mentorship and promoting women in science. 83:913-914. 2018
- Median and dorsal raphe serotonergic neurons control moderate versus compulsive cocaine intake. 83:1024-1035. 2018
- Novel small-molecule inhibitors of protein kinase c epsilon reduced ethanol consumption in mice. 84:193-201. 2018
- The lateral habenula directs coping styles under conditions of stress via recruitment of the endocannabinoid system. 84:611-623. 2018
- Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype. 82:500-510. 2017
- Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats. 81:606-615. 2017
- Neuron-targeted caveolin-1 improves molecular signaling, plasticity, and behavior dependent on the hippocampus in adult and aged mice. 81:101-110. 2017
- Novel dopamine therapeutics for cognitive deficits in schizophrenia. 81:67-77. 2017
- Stress promotes drug seeking through glucocorticoid-dependent endocannabinoid mobilization in the prelimbic cortex. 84:85-94. 2017
- Susceptibility and resilience to posttraumatic stress disorder-like behaviors in inbred mice. 82:924-933. 2017
- Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. 80:179-189. 2016
- Corticotropin-Releasing Factor From Rodents to Primates: Translational Hope Expresses Itself, Pun Intended. 80:340-342. 2016
- G protein-gated K+ channel ablation in forebrain pyramidal neurons selectively impairs fear learning. 80:796-806. 2016
- Regulator of G-protein signaling 7 regulates reward behavior by controlling opioid signaling in the striatum. 80:235-245. 2016
- Genome-wide association studies of substance use: considerations regarding populations and phenotypes.. 77:423-424. 2015
- Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans. 77:870-879. 2015
- Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly. 77:805-815. 2015
- The central amygdala as an integrative hub for anxiety and alcohol use disorders. 77:859-869. 2015
- Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation. 76:57-65. 2014
- Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization. 75:96-104. 2014
- A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. 73:721-8. 2013
- Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction. 74:520-528. 2013
- Beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. 71:714-724. 2012
- Nociceptin/orphanin fq blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure. 71:666-676. 2012
- Neuropeptide y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. 69:1091-1099. 2011
- Preclinical validation of a novel cocaine exposure therapy for relapse prevention. 70:593-598. 2011
- Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: Factor in the transition to dependence. 68:240-248. 2010
- Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. 67:831-839. 2010
- Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. 67:804-811. 2010
- Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats. 68:956-963. 2010
- Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. 66:191-195. 2009
- The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. 63:821-831. 2008
- Abnormal auditory n100 amplitude: A heritable endophenotype in first-degree relatives of schizophrenia probands. 64:1051-1059. 2008
- Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. 64:211-218. 2008
- Inactivation of the 5-ht7 receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. 63:98-105. 2008
- Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion. 63:158-163. 2008
- Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. 63:152-157. 2008
- The opioid peptides enkephalin and beta-endorphin in alcohol dependence. 64:989-997. 2008
- Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis. 64:958-965. 2008
- Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. 61:78-86. 2007
- Distinct patterns of neural activation associated with ethanol seeking: Effects of naltrexone. 61:979-989. 2007
- Successful aging: From phenotype to genotype. 62:282-293. 2007
- Tic symptom profiles in subjects with tourette syndrome from two genetically isolated populations. 61:292-300. 2007
- A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle. 57:1147-1152. 2005
- Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder. 57:711-715. 2005
- 5-HT(7) receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. 58:831-837. 2005
- A polymorphism of the beta(1)-adrenergic receptor is associated with low extraversion. 56:217-224. 2004
- Reduction of anxiety after restricted feeding in the rat: Implication for eating disorders. 55:1075-1081. 2004
- Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. 54:49-58. 2003
- Apolipoprotein d levels are elevated in prefrontal cortex of subjects with alzheimer's disease: No relation to apolipoprotein e expression or genotype. 54:136-141. 2003
- Increased levels of apolipoprotein e in the frontal cortex of subjects with schizophrenia. 54:616-622. 2003
- Sleep deprivation as a probe of homeostatic sleep regulation in primary alcoholics. 51:632-641. 2002
- Auditory p3a deficits in male subjects at high risk for alcoholism. 49:726-738. 2001
- EEG asymmetry: Relationship to mood and risk for alcoholism in Mission Indian youth. 50:129-136. 2001
- Auditory p3a assessment of male alcoholics. 48:276-286. 2000
- Corticotropin-releasing factor, norepinephrine, and stress. 46:1167-1180. 1999
- Electroencephalographic responses to alcohol challenge in Native American Mission Indians. 45:776-787. 1999
- Visual p3a in male subjects at high risk for alcoholism. 46:281-291. 1999
- Gender differences in electrophysiological responses to facial stimuli. 44:281-289. 1998
- Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia. 43:887-896. 1998
- Anterior medial temporal lobe volumes in polydipsic schizophrenic patients with and without hypo-osmolemia: A pilot study. 42:767-770. 1997
- Dopamine-related genes and their relationships to monoamine metabolites in csf. 40:1032-1043. 1996
- Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder: Relationship to risk for alcoholism?. 39:720-732. 1996
- Estimation of the time course of slow-wave sleep over the night in depressed patients: Effects of clomipramine and clinical response. 39:171-181. 1996
- Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: Markers of vulnerability or disease?. 40:825-833. 1996
- Prefrontal cortex dysfunction in borna disease virus (bdv)-infected rats. 40:629-636. 1996
- Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds. 36:680-688. 1994
- Persistent effects of antidepressants - EEG sleep studies in depressed-patients during maintenance treatment. 35:781-793. 1994
- The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers - a preliminary-report. 35:843-849. 1994
- Effects of alcohol on the EEG in Asian men with genetic variations of ALDH2. 34:91-99. 1993
- Effects of gender and social-isolation on electroencephalogram and neuroendocrine parameters in rats. 33:358-366. 1993
- EEG sleep profiles and recurrent depression. 30:641-655. 1991
- EEG fast frequency activity in the sons of alcoholics. 27:631-641. 1990
- EEG sleep in young depressives - first and second night effects. 25:87-97. 1989
- P300 latency after ethanol ingestion in sons of alcoholics and in controls. 24:310-315. 1988
- Reduced beta-casein levels in milk samples from patients with postpartum psychosis. 23:115-122. 1988
- Hypothalamic peptide modulation of EEG sleep in depression - a further application of the S-process hypothesis. 22:513-517. 1987
- Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. 21:23-33. 1986
- Supersensitive endocrine response to physostigmine in dopamine-depleted rats - a model of depression. 21:775-786. 1986
- Pharmacological treatment following experimental cerebral infarction - implications for understanding psychological symptoms of human stroke. 12:669-680. 1977
- Norepinephrine mediated cerebellar synapses: A model system for neuropsychopharmacology. 4:157-177. 1972